← Home / iSpecimen Inc. (ISPC)
Stock Analysis

iSpecimen Inc. (ISPC)

ISPC
ISPC · Healthcare • Diagnostics & Research
1.69 -25.55%
Track ISPC in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when ISPC price is:
52W Range Position
0%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-08-24 02:45 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and structural levels before acting.
⚖️
Fundamentals
Weak / Negative
Price Structure
Vulnerable
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
No reliable structural support level is currently available.
Not available
Break Above
No reliable confirmation level is currently available.
Not available
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
Recent Company Events
SEC VERIFIED
Latest material filings
AUG
14
Material Agreement
MEDIUM
ISPC material agreement
(the “Company”) entered into a Consulting Agreement (the “Consulting Agreement”) with IR Agency LLC (the “Consultant”), pursuant to which the Consultant agreed to provide marketing and advertising services designed to communicate information about the Company to the financial community, including the creation of com...
8-K Filing SEC EDGAR
AUG
11
Material Agreement
HIGH
ISPC material agreement
(the “Company”) entered into a Settlement Agreement and Mutual Release (the “Settlement Agreement”) with WestPark Capital, Inc.
8-K Filing SEC EDGAR
AUG
7
Material Agreement
HIGH
ISPC material agreement
(the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with E.F.
8-K Filing SEC EDGAR
What's Driving ISPC?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
Full Analysis Workspace
Technical Signal
No Active Technical Setup
No qualified technical setup is currently active.
RSI(14)
34.1
Price Chart
ISPC — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-21
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$5.7M
Company size
EV
$669,603
Debt-adjusted value
P/S
5.6
Balanced
P/B
0.2
Low book multiple
EV/Sales
0.7
Low sales multiple
EV/EBIT
-0.0
Not meaningful
P/FCF
-1.0
Not meaningful
Not financial advice
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
Revenue Growth
Weak
Profitability
Negative
Cash Flow
Recovering
Balance Sheet
Manageable
💵 Revenue
151,940
↘ Weak
📈 Net Income
-1.36M
↘ Negative
🧮 EPS (Basic)
-0.98
↘ Negative
iSpecimen Inc.
Healthcare • Diagnostics & Research